Revenue and GTM
Benefit check bot
Revenue: $250K-$2M ARR potential if the wedge proves budget urgency and becomes a recurring workflow.
GTM: Start with manual concierge output, direct outreach, and community proof before paid acquisition.
Execution: Execution is high; the main constraint is staying narrow enough for a first proof loop.
Recovery-percentile tracker for orthopedic surgery patients
Revenue: $250K-$2M ARR potential if the wedge proves budget urgency and becomes a recurring workflow.
GTM: Start with manual concierge output, direct outreach, and community proof before paid acquisition.
Execution: Execution is high; the main constraint is staying narrow enough for a first proof loop.
Which founder should pick which?
Both ideas skew toward the Research Strategist. Recovery-percentile tracker for orthopedic surgery patients is the cleaner first test for that founder because it combines validation score, confidence, and execution difficulty more favorably; Benefit check bot fits when the founder has stronger access to that buyer.
- Benefit check bot: You spot uneven information quality, package evidence, and sell clarity to teams that make repeated decisions.
- Recovery-percentile tracker for orthopedic surgery patients: You spot uneven information quality, package evidence, and sell clarity to teams that make repeated decisions.